trending Market Intelligence /marketintelligence/en/news-insights/trending/d-Ef0WyYYlArgNw4CyHDGQ2 content esgSubNav
In This List

Esperion Therapeutics appoints director

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation

Blog

Using Credit Analytics to Avoid Mispricing Insurance Premiums

Blog

Post-Webinar Q&A: Integrating Climate Risks into Credit Risk Portfolios


Esperion Therapeutics appoints director

Esperion Therapeutics Inc. appointed Jeffrey Berkowitz as a class 2 director of the company.

Berkowitz's term expires at the Ann Arbor, Mich.-based company's 2018 annual shareholders meeting.

He was previously an executive vice president of Optum Inc., UnitedHealth Group Inc.'s health services platform business.